Inventor · disambiguated record
Dalibor Sames
Also filed as: SAMES DALIBOR
15 granted patents·14 pending applications·134 citations·filing 1998–2024
92Inventor score
Files withUNIV COLUMBIA11KRUEGEL ANDREW C3SLOAN KETTERING INST CANCER3DANISHEFSKY SAMUEL J2KRUEGEL ANDREW2
Top patents by PatentIndex Score
29 records- 0193US11912707B2Mitragynine alkaloids as opioid receptor modulatorsUNIV COLUMBIA·Filed 2021·Granted Feb 27, 2024·3 cites·11 claims
- 0291US10961244B2Mitragynine alkaloids as opioid receptor modulatorsUNIV COLUMBIA·Filed 2017·Granted Mar 30, 2021·6 cites·11 claims
- 0389US11760758B2Mitragynine analogs for the treatment of pain, mood disorders and substance use disordersUNIV COLUMBIA·Filed 2021·Granted Sep 19, 2023·6 cites·14 claims
- 0487US8337941B2Fluorescent substrates for monoamine transporters as optical false neurotransmittersGUBERNATOR NIKO GERT·Filed 2007·Granted Dec 25, 2012·30 cites·8 claims
- 0582US7160856B2α-O-linked glycoconjugates, methods of preparation and uses thereofSLOAN KETTERING INST CANCER·Filed 2002·Granted Jan 9, 2007·17 cites·47 claims
- 0681US9988377B2Small molecule inducers of GDNF as potential new therapeutics for neuropsychiatric disordersSAMES DALIBOR·Filed 2012·Granted Jun 5, 2018·7 cites·26 claims
- 0781US9075014B2pH-responsive fluorescent false neurotransmitters and their useSAMES DALIBOR·Filed 2011·Granted Jul 7, 2015·7 cites·14 claims
- 0880US10183919B2Class of mu-opioid receptor agonistsKRUEGEL ANDREW C·Filed 2015·Granted Jan 22, 2019·8 cites·37 claims
- 0980US2025122213A1Opioid receptor modulatorsUNIV COLUMBIA·Filed 2024·Application pending·0 cites
- 1079US6660714B1α-O-linked glycoconjugates, methods of preparation and uses thereofSLOAN KETTERING INST CANCER·Filed 1998·Granted Dec 9, 2003·36 cites·58 claims
- 1177US12195478B2Opioid receptor modulatorsUNIV COLUMBIA·Filed 2023·Granted Jan 14, 2025·0 cites·18 claims
- 1277US7550146B2Glycopeptide conjugates and uses thereofSLOAN KETTERING INST CANCER·Filed 2004·Granted Jun 23, 2009·11 cites·69 claims
- 1369US11840541B2Opioid receptor modulatorsKRUEGEL ANDREW C·Filed 2015·Granted Dec 12, 2023·1 cites·27 claims
- 1469US11787772B2Carboxylic diarythiazepineamines as mixed mu- and delta-opioid receptor agonistsKRUEGEL ANDREW·Filed 2018·Granted Oct 17, 2023·1 cites·23 claims
- 1567US10844027B2Carboxylic diarylthiazepineamines as mu-opioid receptor agonistsKRUEGEL ANDREW·Filed 2016·Granted Nov 24, 2020·1 cites·21 claims
- 1667US2024109836A1Non-hallucinogenic ariadne analogs for treatment of neurological and psychiatric disordersUNIV COLUMBIA·Filed 2023·Application pending·0 cites
- 1764US2022106279A1Class of mu-opioid receptor agonistsUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 1858US2023382919A1Oxa- ibogaine inspired analogues for treatment of neurological and psychiatric disordersUNIV COLUMBIA·Filed 2023·Application pending·0 cites
- 1952US2023250098A1Kratom opioid derivatives for the treatment of alcohol use disorderUNIV OF HEALTH SCIENCES & PHARMACY IN ST LOUIS·Filed 2022·Application pending·0 cites
- 2052US2024118210A1Ffn fluorescence release assay (ffra) and methods of using sameUNIV DUKE·Filed 2022·Application pending·0 cites
- 2151US8859615B2Compounds, compositions and methods for reducing toxicity and treating or preventing diseasesDANISHEFSKY SAMUEL J·Filed 2009·Granted Oct 14, 2014·0 cites·18 claims
- 2250US2024150372A1Oxa-ibogaine analogues for treatment of substance use disordersUNIV COLUMBIA·Filed 2022·Application pending·0 cites
- 2349US2023348465A1Ibogaine analogs as therapeutics for neurological and psychiatric disordersUNIV COLUMBIA·Filed 2021·Application pending·0 cites
- 2449US2019084949A1New class of mu-opioid receptor agonistsKRUEGEL ANDREW C·Filed 2018·Application pending·0 cites
- 2548US2022135564A1Deuterated mitragynine analogs as safer opioid modulators in the mitragynine classUNIV COLUMBIA·Filed 2020·Application pending·0 cites
- 2646US2013190497A1Fluorescent substrates for monoamine transporters as optical false neurotransmittersOF NEW YORK THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY·Filed 2012·Application pending·0 cites
- 2745US2004102607A1Trimeric antigenic O-linked glycopeptide conjugates, methods of preparation and uses thereofFiled 2003·Application pending·0 cites
- 2845US2010048604A1Ligands for AldoketoreductasesYEE DOMINIC J·Filed 2005·Application pending·0 cites
- 2945US2011124690A1Compositions and methods for treating cancer or a neurotrophic disorderDANISHEFSKY SAMUEL J·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dalibor Sames files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →